The targeting of human and mouse B lymphocytes by dasatinib.
Saved in:
| Title: | The targeting of human and mouse B lymphocytes by dasatinib. |
|---|---|
| Authors: | Oksvold MP; Department of Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway. Electronic address: moroks@rr-research.no., Duyvestyn JM; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Australia., Dagger SA; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Australia., Taylor SJ; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Australia., Forfang L; Department of Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway., Myklebust JH; Department of Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway., Smeland EB; Department of Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway., Langdon WY; School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Australia. |
| Source: | Experimental hematology [Exp Hematol] 2015 May; Vol. 43 (5), pp. 352-363.e4. Date of Electronic Publication: 2015 Jan 29. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Science Inc Country of Publication: Netherlands NLM ID: 0402313 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2399 (Electronic) Linking ISSN: 0301472X NLM ISO Abbreviation: Exp Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
